Palisade Bio Inc (PALI)

Mar 11, 2026

RSI Check: Will Palisade Bio Inc outperform its industry peers2026 Trends & Technical Pattern Recognition Alerts - baoquankhu1.vn

Mar 11, 2026

Mar 07, 2026

Aug Macro: Can Palisade Bio Inc maintain sales growth2025 Buyback Activity & Safe Capital Preservation Plans - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

Published on: 2026-03-07 13:46:23 - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

US Market Recap: Will Palisade Bio Inc stock recover after earningsTrade Volume Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Mar 06, 2026

Mar 05, 2026

Treasury Yields: Will Palisade Bio Inc benefit from current market trends2025 Winners & Losers & Community Consensus Trade Signals - baoquankhu1.vn

Mar 05, 2026

Mar 04, 2026

PALI SEC FilingsPalisade Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026

Mar 04, 2026

Short Interest in Palisade Bio, Inc. (NASDAQ:PALI) Rises By 20.2% - MarketBeat

Mar 04, 2026

Mar 02, 2026

Palisade Bio Announces Participation in Two Upcoming Investor Conferences - Bitget

Mar 02, 2026

Mar 01, 2026

Palisade Bio Details PALI-2108 UC, Crohn’s Plans and Cash Runway Into 2029 at Oppenheimer Conference - MarketBeat

Mar 01, 2026

Feb 28, 2026

Palisade Bio (NASDAQ:PALI) Upgraded to "Hold" at Wall Street Zen - MarketBeat

Feb 28, 2026

Feb 28, 2026

Palisade Bio (NASDAQ:PALI) Upgraded to “Hold” at Wall Street Zen - Defense World

Feb 28, 2026

Feb 28, 2026

PALI Should I Buy - Intellectia AI

Feb 28, 2026

Feb 26, 2026

PALI: Advancing a once-daily, gut-restricted PDE4 inhibitor with strong funding and pivotal trials ahead - TradingView

Feb 26, 2026

Feb 25, 2026

Palisade Bio (NASDAQ:PALI) Now Covered by Stifel Nicolaus - MarketBeat

Feb 25, 2026

Feb 25, 2026

Stifel Initiates Palisade Bio at Buy With $5 Price Target - marketscreener.com

Feb 25, 2026

Feb 25, 2026

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Feb 25, 2026

Feb 25, 2026

Palisade Bio (PALI) Sees New 'Buy' Rating from Stifel | PALI Sto - GuruFocus

Feb 25, 2026

Feb 25, 2026

Stifel Initiates Coverage of Palisade Bio (PALI) with Buy Recommendation - Nasdaq

Feb 25, 2026

Feb 25, 2026

Stifel initiates Palisade Bio stock with buy rating on IBD drug - Investing.com Australia

Feb 25, 2026

Feb 24, 2026

PALI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Feb 24, 2026

Stifel initiates Palisade Bio stock with buy rating on IBD drug By Investing.com - Investing.com Canada

Feb 24, 2026

Feb 24, 2026

Palisade Bio Strengthens Advisory Board, Fast-tracks Key Research Developments - timothysykes.com

Feb 24, 2026

Feb 24, 2026

Palisade Bio presents ulcerative colitis drug trial data at ECCO By Investing.com - Investing.com India

Feb 24, 2026

Feb 23, 2026

Palisade Bio presents ulcerative colitis drug trial data at ECCO - Investing.com

Feb 23, 2026

Feb 23, 2026

Palisade Bio, Inc. Presents Phase 1b Data Demonstrating Localized Target Engagement and Early Clinical Response of PALI-2108 in Ulcerative Colitis at ECCO 2026 - Quiver Quantitative

Feb 23, 2026

Feb 23, 2026

Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026 - Bitget

Feb 23, 2026

Feb 23, 2026

Palisade Bio Reports Rapid Clinical, Histologic and New - GlobeNewswire

Feb 23, 2026

Feb 20, 2026

Palisade Bio, Inc. (NASDAQ:PALI) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Feb 20, 2026

Feb 19, 2026

Palisade Bio, Inc. (NASDAQ:PALI) Sees Large Increase in Short Interest - Defense World

Feb 19, 2026

Feb 17, 2026

Palisade Bio appoints IBD expert to clinical advisory board By Investing.com - Investing.com Canada

Feb 17, 2026

Feb 17, 2026

Perceptive fund discloses 9.99% Palisade Bio (PALI) ownership stake - Stock Titan

Feb 17, 2026

Feb 17, 2026

Palisade Bio appoints IBD expert to clinical advisory board - Investing.com

Feb 17, 2026

Feb 17, 2026

Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board - Bitget

Feb 17, 2026

Feb 17, 2026

Palisade Bio Strengthens Clinical Advisory Board with Appointment of Dr. Bram Verstockt to Advance PALI-2108 Development in Ulcerative Colitis and Crohn's Disease - Quiver Quantitative

Feb 17, 2026

Feb 17, 2026

Ulcerative colitis drug PALI-2108 gets boost from new IBD advisor - Stock Titan

Feb 17, 2026

Feb 14, 2026

Palisade Bio (PALI) chief medical officer Jones sells $3480 in stock - Investing.com UK

Feb 14, 2026

Feb 13, 2026

Can Palisade Bio Inc. (7NS0) stock resist broad market declinesPortfolio Risk Report & Precise Trade Entry Recommendations - mfd.ru

Feb 13, 2026

Feb 13, 2026

Palisade Bio (PALI) chief medical officer Jones sells $3480 in stock By Investing.com - Investing.com Australia

Feb 13, 2026

Feb 13, 2026

Palisade Bio CEO Finley sells $6818 in shares - Investing.com South Africa

Feb 13, 2026

Feb 13, 2026

Palisade Bio CEO Finley sells $6818 in shares By Investing.com - Investing.com India

Feb 13, 2026

Feb 13, 2026

Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Feb 13, 2026

Feb 13, 2026

Can Palisade Bio Inc. maintain sales growthJuly 2025 Chart Watch & Accurate Buy Signal Notifications - mfd.ru

Feb 13, 2026

Feb 11, 2026

Palisade Bio (PALI) awards Chief Medical Officer 787,000 RSUs - Stock Titan

Feb 11, 2026

Feb 09, 2026

Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium - GlobeNewswire

Feb 09, 2026

Feb 07, 2026

Palisade Bio (NASDAQ:PALI) Lowered to Sell Rating by Wall Street Zen - MarketBeat

Feb 07, 2026

Feb 06, 2026

Aug Shorts: Will Palisade Bio Inc outperform its industry peers2025 Retail Activity & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Feb 06, 2026

Feb 05, 2026

Aug Sentiment: Is Palisade Bio Inc stock a good pick for beginners2025 Volume Leaders & Safe Capital Investment Plans - baoquankhu1.vn

Feb 05, 2026

Feb 05, 2026

Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - marketscreener.com

Feb 05, 2026

Feb 05, 2026

Palisade Bio leaders set for virtual Oppenheimer healthcare conference slot - Stock Titan

Feb 05, 2026